瑞联新材(688550) - 2025 Q2 - 季度业绩预告

Xi'an Remian New Materials Co., Ltd. 2025 Semi-Annual Performance Forecast Core Performance Forecast Data The company projects significant growth in H1 2025, with revenue increasing by 16.27% to RMB 806 million and net profit attributable to shareholders by 69.93% to RMB 162 million, based on unaudited preliminary estimates H1 2025 Performance Forecast (Preliminary) | Metric (RMB Million) | H1 2025 (Projected) | H1 2024 (Prior Period) | Year-over-Year Growth | | :--- | :--- | :--- | :--- | | Operating Revenue | 806.24 | 693.44 | +16.27% | | Net Profit Attributable to Parent Company Shareholders | 161.99 | 95.33 | +69.93% | | Net Profit Attributable to Parent Company Shareholders (Excluding Non-recurring Items) | 157.43 | 87.40 | +80.12% | | Net Profit Attributable to Parent Company Shareholders (Excluding Share-based Payments) | 178.23 | 97.97 | +81.91% | | Net Profit Attributable to Parent Company Shareholders (Excluding Share-based Payments and Non-recurring Items) | 173.66 | 90.05 | +92.86% | - The financial data in this performance forecast represents preliminary estimates by the company's finance department and remains unaudited[4] Prior Period Performance Review In H1 2024, the company reported a net profit attributable to parent company owners of RMB 95.33 million and basic earnings per share of RMB 0.55, serving as the baseline for current period growth projections H1 2024 Performance Data | Metric | H1 2024 Data | | :--- | :--- | | Total Profit | 108.88 Million RMB | | Net Profit Attributable to Parent Company Shareholders | 95.33 Million RMB | | Net Profit Attributable to Parent Company Shareholders (Excluding Non-recurring Items) | 87.40 Million RMB | | Basic Earnings Per Share | 0.55 RMB | Performance Growth Drivers H1 2025 performance growth is primarily attributed to robust pharmaceutical sector performance, optimized product structure, and enhanced cost control measures, collectively boosting profitability - Revenue from the pharmaceutical sector achieved significant year-over-year growth[7] - Optimized product structure led to an increase in the company's overall gross margin[7] - The company continuously strengthened cost control and efficiency improvements, enhancing profitability[7] Risk Warning The company cautions that the preliminary, unaudited performance forecast data may differ from the final semi-annual report, advising investors to consider investment risks and rely on official disclosures - The company has not currently identified any significant uncertainties that might affect the accuracy of this performance forecast[8] - The performance forecast data is unaudited, and final figures will be subject to the company's officially disclosed 2025 semi-annual report, advising investors to exercise caution regarding investment risks[8]